Cell Isolation Market 2024 - By Industry Size, Future Prediction, Business Trends And Forecast To 2033

The cell isolation market size has grown rapidly in recent years. It will grow from $4.13 billion in 2023 to $4.65 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to regulatory support and guidelines, adoption of single-cell analysis, expansion of biopharmaceutical industry, growth of stem cell research, escalating aging population.

The cell isolation market size is expected to see rapid growth in the next few years. It will grow to $7.4 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to rising demand for cell-based assays, adoption of microfluidics-based technologies, increasing funding for life sciences research, expansion of biopharmaceutical industry, expanding research in areas like cancer and regenerative medicine. Major trends in the forecast period include automation and robotics integration, multiplexed cell isolation, integration of artificial intelligence (AI), single-cell isolation and analysis, miniaturization and portability.

Market Overview -
Cell isolation refers to the process of separating individual living cells from a solid block of tissue or cell suspension. This technique is vital in research fields such as stem cell and oncology studies, as well as clinical diagnostics, to separate specific cell populations from heterogeneous samples by targeting unique characteristics such as size, charge, density, shape, or protein expression.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=14872&type=smp

Role Of Chronic Disease Prevalence In Driving Growth In The Cell Isolation Market
The rising prevalence of chronic diseases is expected to propel the growth of the cell isolation market going forward. Chronic diseases refer to long-term health conditions that persist over an extended period, often for years or even a lifetime. The prevalence of chronic diseases requires a multifaceted approach that includes public health interventions, policies to promote healthy lifestyles, improvements in healthcare infrastructure, and increased awareness and education. The increasing prevalence of chronic diseases drives advancements in cell isolation technologies and research, offering new opportunities to harness the potential of stem cells for regenerative medicine and the treatment of various health conditions. For instance, in May 2023, according to reports published by the Centers for Disease Control and Prevention (CDC.gov)., a US-based government organization, heart disease and cancer deaths totaled 6,95,547 in 2022, which is an increase from the previous year compared to 6,05,213 in 2021. Therefore, the rising prevalence of chronic diseases is driving the growth of the cell isolation market.

Competitive Landscape -
Major companies operating in the cell isolation market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merk Co. & KGaA, GE Healthcare Company, Becton Dickinson & Company, Corning Inc., Lonza Inc., Agilent Technologies Inc., Alfa Laval AB, PerkinElmer Inc., Sartorius AG, Terumo Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen NV, Bio-Techne Corporation, STEMCELL Technologies Inc., Cytek Biosciences Inc., Miltenyi Biotec Inc., Neogenomics Laboratories Inc., Promega Corporation, Takara Bio Inc., Molecular Devices LLC, NanoString Technologies Inc., Proteintech Group Inc., Sony Biotechnology Inc., PluriSelect Life Science UG & Co. KG, Invent Biotechnologies Inc., Akadeum Life Sciences Inc.

Innovations Driving Growth In the Cell Isolation Market
Major companies operating in the cell isolation market are focusing on technological advancements such as the closed cell isolation system to enhance cell purity, streamline workflows, and improve the efficiency of cell-based research and therapeutic applications. This cell sorting instrument isolates specific cells or cell populations from a heterogeneous sample, such as blood or tissue, while minimizing contamination and preserving cell viability. For instance, in January 2022, Sony Corporation, a Japan-based conglomerate corporation, launched the new closed cell isolation system CGX10 to produce advanced cell therapy products. The introduction of CGX10 by Sony's Life Science business extends beyond research applications into the development and manufacturing of cell therapies, aiding in advancing fields like cell therapy and regenerative medicine. This product facilitates the creation of GMP-compliant manufacturing processes for cellular products, broadening Sony's contribution to the progression of cell therapy.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/cell-isolation-global-market-report

Key Segments -
The cell isolation market covered in this report is segmented -
1) By Product: Consumables, Instruments
2) By Cell Type: Human Cells, Animal Cells
3) By Cell Source: Bone Marrow, Adipose Tissues, Cord Blood Or Embryonic Stem Cells, Other Cell Sources
4) By Application: Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration Or Regenerative Medicines, In-vitro Diagnostics, Other Applications
5) By End-User: Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Hospitals And Diagnostic Laboratories, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.